Autolus Therapeutics (AUTL) Change in Cash (2018 - 2025)

Autolus Therapeutics (AUTL) has 8 years of Change in Cash data on file, last reported at $18.0 million in Q4 2025.

• For the quarter ending Q4 2025, Change in Cash rose 104.19% year-over-year to $18.0 million; the trailing twelve-month figure through Dec 2025 stood at -$123.2 million (down 968.26% YoY), and the FY2025 full-year result was -$123.2 million, down 968.26% from the prior year.
• Change in Cash for Q4 2025 stood at $18.0 million, up from -$37.7 million in the prior quarter.
• Across five years, Change in Cash topped out at $519.2 million in Q1 2024 and bottomed at -$429.7 million in Q4 2024.
• The 5-year median for Change in Cash is -$38.6 million (2023), against an average of -$2.4 million.
• Peak annual rise in Change in Cash reached 1417.59% in 2024, while the deepest fall reached 2502.23% in 2024.
• A 5-year view of Change in Cash shows it stood at $137.4 million in 2021, then surged by 59.67% to $219.4 million in 2022, then tumbled by 107.53% to -$16.5 million in 2023, then sank by 2502.23% to -$429.7 million in 2024, then surged by 104.19% to $18.0 million in 2025.
• The last three Change in Cash figures came in at $18.0 million (Q4 2025), -$37.7 million (Q3 2025), and $28.1 million (Q2 2025), per Business Quant data.

Peer Comparison